Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

2016456 citationsReviewhybrid Open Access

Authors

Nintedanib has a beneficial effect on slowing disease progression in patients with IPF.

Good health and well-being

Published in: Respiratory Medicine

Volume 113, pp. 74-79

Field-Weighted Citation Impact: 44.33